| abstract |
The present disclosure provides pyrimidine compounds of Formula 1 and uses thereof, for example, for the treatment of diseases associated with P2X purinergic receptors. In certain aspects, the present disclosure provides P2X3 and/or P2X2/3 antagonists useful, for example, in the potential treatment of visceral organs, cardiovascular and pain-related diseases, conditions and disorders. |